US: +1-800-981-5864CA: +1-647-370-8281AU: +61-48-207-5486UK: +44-20-3835-4834FR: +33-64-463-9941ES: +34-51-889-9156NZ: +64-80-074-8315DK: +45-52-51-72-02SE: +46-77-421-88-58CH: +41-43-508-24-74CZ: +420-228-885-478FI: +358-9-4245-3635GR: +30-21-1199-2166PT: +351-923-294-983DE: +49-162-664-6525IT: +39-350-850-7594NL: +31-970-102-87367
Kisqali
Ribociclib

Kisqali

Tillbaka till katalogen

Kisqali (ribociklib) je ciljno zdravilo, ki se uporablja za zdravljenje raka dojke s pozitivnim hormonskim receptorjem (HR+) in negativnim HER2 [HR+ HER2-] statusom, zlasti v zgodnji fazi (z visokim tveganjem) ali napredovalih/metastatskih primerih. Jemlje se v kombinaciji z endokrino terapijo (zaviralci aromataze ali fulvestrant) za zaviranje rasti rakavih celic.

Aktiv substans
Ribociclib

Kisqali 200mg

3 paket
PaketPer tablettSpecialpris
5 pills
Fri frakt
$117.00
$965.00 -40%
Endast $585.00
3 pills
Fri frakt
$129.67
$579.00 -33%
Endast $389.00
1 pills
$193.00
Endast $193.00
Ni kanske också gillar
-87% Viagra Viagra Sildenafil $0.24-73% Cialis Cialis Tadalafil $0.62-75% Levitra Levitra Vardenafil $1.00-50% Ozempic (Generic) Ozempic (Generic) Semaglutide $214.00-27% Rybelsus Rybelsus Semaglutide $18.33 Trial ED Pack Trial ED Pack Sildenafil, Tadalafil, Vardenafil $4.00


Kisqali is a targeted therapy used to treat hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer, specifically for advanced or metastatic cases or early-stage (II or III) high-risk cases. It is a CDK4/6 inhibitor that blocks proteins encouraging cancer growth.